3. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, et al. A proteomic view of the
Plasmodium falciparum life cycle. Nature 2002;419(6906):520-526
https://doi.org/10.1038/nature01107
6. Healer J, Crawford S, Ralph S, McFadden G, Cowman AF. Independent translocation of two micronemal proteins in developing
Plasmodium falciparum merozoites. Infect Immun 2002;70(10):5751-5758
https://doi.org/10.1128/IAI.70.10.5751-5758.2002
7. Silvie O, Franetich JF, Charrin S, Mueller MS, Siau A, et al. A role for apical membrane antigen 1 during invasion of hepatocytes by
Plasmodium falciparum sporozoites. J Biol Chem 2004;279(10):9490-9496
https://doi.org/10.1074/jbc.M311331200
8. Hodder AN, Crewther PE, Matthew ML, Reid GE, Moritz RL, et al. The disulfide bond structure of
Plasmodium apical membraneantigen-1. J Biol Chem 1996;271:29446-29452
https://doi.org/10.1074/jbc.271.46.29446
9. Udhayakumar V, Kariuki S, Kolczack M, Girma M, Roberts JM, et al. Longitudinal study of natural immune responses to the
Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am J Trop Med Hyg 2001;65(2):100-107
https://doi.org/10.4269/ajtmh.2001.65.100
10. Moncunill G, Aponte JJ, Nhabomba AJ, Dobano C. Performance of multiplex commercial kits to quantify cytokine and chemokine responses in culture supernatants from
Plasmodium falciparum stimulations. PLoS One 2013;8(1):e52587
https://doi.org/10.1371/journal.pone.0052587
11. Rodrigues MH, Rodrigues KM, Oliveira TR, Cômodo AN, Rodrigues MM, et al. Antibody response of naturally infected individuals to recombinant
Plasmodium vivax apical membrane antigen-1. Int J Parasitol 2005;35(2):185-192
https://doi.org/10.1016/j.ijpara.2004.11.003
12. Gentil EC, Damgaard A, Hauschild M, Finnveden G, Eriksson O, et al. Models for waste life cycle assessment: review of technical assumptions. Waste Manag 2010;30(12):2636-2648
https://doi.org/10.1016/j.wasman.2010.06.004
14. Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, et al. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed
Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25–545]) in healthy Malian adults in Bandiagara. Malar J 2016;15(1):442
https://doi.org/10.1186/s12936-016-1466-4
15. Volkman SK, Neafsey DE, Schaffner SF, Park DJ, Wirth DF. Harnessing genomics and genome biology to understand malaria biology. Nat Rev Genet 2012;13(5):315-328
https://doi.org/10.1038/nrg3187
17. Afridi SG, Irfan M, Ahmad H, Aslam M, Nawaz M, et al. Population genetic structure of domain I of apical membrane antigen-1 in
Plasmodium falciparum isolates from Hazara division of Pakistan. Malar J 2018;17(1):389
https://doi.org/10.1186/s12936-018-2539-3
18. Kang JM, Lee J, Moe M, Jun H, Lê HG, et al. Population genetic structure and natural selection of
Plasmodium falciparum apical membrane antigen-1 in Myanmar isolates. Malar J 2018;17(1):71
https://doi.org/10.1186/s12936-018-2215-7
19. Kang JM, Lê HG, Võ TC, Naw H, Yoo WG, et al. Genetic polymorphism and natural selection of apical membrane antigen-1 in
Plasmodium falciparum isolates from Vietnam. Genes (Basel) 2021;12(12):1903
https://doi.org/10.3390/genes12121903
21. Rozas J, Ferrer-Mata A, Sánchez-DelBarrio JC, Guirao-Rico S, Librado P, et al. DnaSP 6: DNA sequence polymorphism analysis of large data sets. Mol Biol Evol 2017;34(12):3299-3302
https://doi.org/10.1093/molbev/msx248
25. Privman E, Penn O, Pupko T. Improving the performance of positive selection inference by filtering unreliable alignment regions. Mol biol and Evol 2012;29(1):1-5
https://doi.org/10.1093/molbev/msr177
29. RTSS Clinical Trials Partnership, Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 2011;365(20):1863-1875
https://doi.org/10.1056/NEJMoa1102287
31. Beeson JG, Kurtovic L, Valim C, Asante KP, Boyle MJ, et al. The RTS, S malaria vaccine: current impact and foundation for the future. Sci Transl Med; 2022. 14(671):eabo6646
https://doi.org/10.1126/scitranslmed.abo6646
33. Rajneesh , Tiwari R, Singh VK, Kumar A, Gupta RP, et al. Advancements and challenges in developing malaria vaccines: targeting multiple stages of the parasite life cycle. ACS Infect Dis 2023;9(10):1795-1814
https://doi.org/10.1021/acsinfecdis.3c00332
34. Bai T, Becker M, Gupta A, Strike P, Murphy VJ, et al. Structure of AMA1 from
Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci U S A 2005;102(36):12736-12741
https://doi.org/10.1073/pnas.0501808102
35. Zhu X, Zhao Z, Feng Y, Li P, Liu F, et al. Genetic diversity of the
Plasmodium falciparum apical membrane antigen I gene in parasite population from the China-Myanmar border area. Infect Genet Evol 2016;39:155-162
https://doi.org/10.1016/j.meegid.2016.01.021
36. Balloux F, Lugon-Moulin N. The estimation of population differentiation with microsatellite markers. Mol Ecol 2002;11(2):155-165.